Biotech Values

[DewDiligence]

…not sure why ABBV didn't PR the [GIFT-1] cirrhotic data…

All cirrhotic patients were in an open-label trial arm (arm “C” in the clinicaltrials.gov listing at https://clinicaltrials.gov/ct2/show/NCT02023099 ) that was independent from the predefined primary endpoint of the trial. The cirrhotic data will presumably be reported when the detailed data are at presented at a medical conference.